Cohort study on obesity, diabetes, and inflammation across different ethnicities
Official title: Development of a Multi-Ethnic, Multimodal Obesity Cohort
Run by University of California, San Francisco · NCT03022682 · Data updated 2026-11-12
This study is trying to understand how obesity, diabetes, and inflammation are connected across different ethnic groups by gathering health information and samples from 350 adults with stable weight.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 350 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | February 2015 |
| Main results expected | December 2029 |
| Study ends | December 2029 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT03022682 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy individuals aged 18-75, with or without diabetes, who have a stable weight and may include those undergoing bariatric surgery.
✕Probably not a fit
Patients with chronic kidney disease, autoimmune diseases, or those with significant comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to recruit 350 participants aged 18-75 from various ethnic backgrounds to investigate the relationship between obesity, diabetes, and inflammation. Participants will provide data and biological samples, including blood, stool, and adipose tissue, to better understand the impact of ethnicity and body mass index on diabetes risk. The study focuses on individuals with stable weight, including those scheduled for bariatric or abdominal surgery, to gather comprehensive insights into these interconnected health issues.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of obesity and diabetes, particularly in diverse populations.
How similar studies have gone: Other studies have shown success in exploring the links between obesity, diabetes, and ethnicity, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants will be healthy individuals between the ages of 18-75 years. These cutoffs are designed to allow inclusion of postmenopausal women, and younger/more active patients who are increasingly undergoing bariatric surgery. * Patients with either diabetes type 2 or the metabolic syndrome will be included in the cohort. Exclusion Criteria: * Participants with chronic kidney disease (\> stage 4) * Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.) * Unstable angina, New York (NY) class III or IV congestive heart failure or myocardial infarction within 3 months of entry * Clinically significant liver disease (e.g. Cirrhosis or liver failure) * Weight \> 450 pounds (DXA scan weight limit) * History of organ transplant * Treatment with chemotherapy or radiation therapy at the time of enrollment in study. * Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oral glucocorticoids) * Current nasal corticosteroid use (within the past month) * Excessive alcohol or substance abuse * Current use of anabolic steroids or testosterone for bodybuilding purposes. Testosterone use is permitted if prescribed for hypogonadism and dose stable for the past 6 months. * Patients actively enrolled in interventional trials involving investigational agents * Pregnant or breast-feeding women * Appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee. * History of abnormal clotting * Previous bariatric surgery * Anticoagulant use * Methadone medication
Where it's running
-
University of California San Francisco
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Suneil Koliwad, MD,PhD — University of California, San Francisco
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital tool for doctors to prescribe exercise for people with cardiovascular risk factors
This project will test whether a new digital tool helps doctors create personalized exercise plans for adults with cardiovascular risk factors.
-
Sisters of Heart: community health worker support to improve heart health in migrant farmworker women
This trial tests whether peer support and help accessing community resources from community health workers can reduce stress and improve heart health measures in Spanish- or English-speaking migrant farmworker women aged 18–45.
-
Integrated Traditional Chinese Medicine Program for Metabolic Syndrome
This study is testing a combined approach of Chinese herbal medicine and laser acupuncture to see if it can help people with metabolic syndrome improve their health over six months.
-
Investigating body fat distribution and its impact on metabolic diseases in Japanese adults
This study looks at how the way body fat is distributed affects the risk of metabolic and heart diseases in Japanese adults.
-
Program to prevent young onset diabetes using genetic and clinical assessments
This study is testing a program that uses genetic and health checks to help young adults at risk of diabetes prevent the disease and learn more about their health.
-
Characterizing blood cells and factors in metabolic diseases
This study looks at the differences in blood cells and other factors in people with metabolic diseases like diabetes and obesity compared to healthy individuals to better understand these conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.